The startup develops in vivo diagnostics using single-domain antibodies for molecular imaging, focusing on immunology, oncology, and cardiology. Their technology enables precise disease diagnosis, treatment selection, and monitoring of treatment response based on specific molecular markers, improving patient outcomes in oncology and cardiovascular care.

AmphiStar develops, scales up, and produces high-performance biosurfactants derived entirely from biobased waste and side streams. These biocompatible ingredients serve diverse markets including home care, personal care, industrial cleaners, textiles, and agrochemicals. The company utilizes patented technology to deliver uniform, pure, and sustainable surfactant solutions that support a circular economy.

ANA Therapeutics develops a novel vaccine to prevent coronavirus infection. Their vaccine aims to provide effective protection against current and future strains of the virus.

Animab develops proprietary biotechnology solutions using oral antibodies to improve livestock gut health and performance. Their technology targets intestinal pathogens, reducing the need for antimicrobials in post-weaning piglets. This approach integrates research and animal science to enhance feed conversion and physiological development in livestock.

Axithra develops a platform utilizing proprietary optical and photonics technology to rapidly and accurately measure drug concentrations in blood, enabling personalized treatment plans for patients. The initial focus is on optimizing beta-lactam antibiotic therapies in intensive care units, enhancing drug effectiveness and minimizing adverse reactions.

Callic develops technology to harvest ambient heat from open water sources for use as a renewable energy source. Their systems enable the large-scale deployment of aquathermy, providing a reliable and widely applicable heating solution. Callic focuses on open aquathermy systems.

Cascador Health provides a GDPR‑compliant platform that aggregates and anonymizes real‑world health data from European providers, delivering curated datasets through a secure portal for secondary use. The service handles data integration, governance, and privacy, enabling pharmaceutical companies, medical‑device firms, researchers, and regulators to generate therapeutic‑outcome insights, support market‑access strategies, and monitor safety with minimal workload for healthcare providers.

Cen utilizes blockchain technology to create a crowdsourced knowledge base that combines human and artificial intelligence, enabling real-time learning and context-aware interactions. The platform addresses the centralization of AI data ownership and the fragility of AI decision-making by allowing users to maintain control over their data while contributing to a collective intelligence resource.

eyeo develops next-generation image sensors utilizing proprietary color splitting technology based on nano-photonic structures. This approach eliminates traditional color filter light loss, resulting in enhanced sensitivity and superior low-light performance. The technology enables higher resolution and improved color accuracy for applications in consumer electronics, automotive vision, and medical imaging.

Flindr Therapeutics develops first-in-class small molecule inhibitors targeting oncogenic driver RNF31 for precision cancer treatment, utilizing its ImmunoGram Drug Discovery Engine to identify novel drug targets in cancer and immune cells. The company aims to enhance treatment efficacy and patient outcomes in oncology by advancing a pipeline of innovative therapies.

Indigo is an AI-powered home transaction platform that centralizes communication, bidding, and contract management for real estate agents, buyers, and sellers, enhancing transparency and efficiency throughout the transaction process. By automating contract generation and providing real-time analytics, Indigo reduces communication time by 80% and increases offer acceptance rates, streamlining the home buying and selling experience.

This company designs and sells advanced orthopedic insoles engineered for both casual comfort and high-level athletic performance. Their product line features patented arch support technology to enhance foot health and endurance during activity. They provide pro-level foot support solutions accessible to the general consumer market.

MRM Health develops therapeutics using its proprietary CORAL® platform, which combines selected bacterial strains into optimized consortia manufactured as a single drug substance. This approach addresses the challenges of engraftment and efficacy in microbiome-based therapies, particularly for inflammatory bowel diseases and other conditions.

Obulytix develops Precision Lysin Therapeutics (PLTs), a new class of targeted biologics designed as next-generation antibiotics. These engineered treatments selectively eliminate bacteria while actively avoiding the development of antimicrobial resistance (AMR). The company provides innovative solutions to combat multidrug-resistant strains and safeguard modern medical capabilities.

PIC Therapeutics develops small molecule precision therapeutics that modulate the Pre-Initiation Complex to selectively inhibit oncogene protein production in cancer cells. This approach targets the underlying mechanisms of therapeutic resistance and tumor complexity, aiming to improve treatment efficacy for patients with unmet medical needs.

Pleevi provides intelligent energy management software for EV charging infrastructure, offering simulation tools for strategic planning and real-time optimization for operations. Their platform uses AI forecasting and mathematical optimization to reduce energy costs and prevent grid overloads across workplaces, depots, and charging sites. This results in significant energy cost savings while ensuring vehicles are charged efficiently according to demand and site constraints.

This company develops and supplies heavy-metal-free quantum dot (QD) materials, including inkjet inks, dispersions, and resins, for advanced color conversion applications. Their QustomJet™ inks enable high-performance, wide-gamut, and energy-efficient displays across microLED, miniLED, and OLED technologies. They offer customized QD formulations tailored for specific manufacturing processes and high-resolution patterning requirements.

RA UNLIMITED harnesses solar photovoltaic technology to generate clean and affordable electricity for homes, businesses, and communities in the Philippines. The company addresses the reliance on fossil fuels by providing sustainable energy solutions that create jobs and enhance the quality of life for Filipinos.

Rainbow Crops utilizes the Trait Foundry™ platform to engineer complex traits in crops through advanced biotechnology. This platform integrates multiplex genome editing, precision breeding, and AI-driven analysis of plant omics data. The result is the development of resilient crop varieties designed to enhance food security against environmental challenges.

The startup offers a cashless payment platform that enables consumers to save on parking costs while earning reward points at local merchants. By integrating automated reimbursement features, the platform enhances local consumption for retailers and municipalities, providing measurable financial benefits to users.

Tailos develops Rosie, a commercial-grade robotic vacuum that utilizes Simultaneous Localization and Mapping (SLAM) technology to navigate indoor environments without pre-mapping. By automating floor cleaning, Rosie reduces labor costs by up to $4,000 per month and enhances cleanliness in hospitality settings, addressing staffing shortages and operational inefficiencies.

THERAtRAME develops first-in-class small molecules that target tRNA epitranscriptomics to create new therapeutic options for patients with untreatable cancers. By leveraging advanced screening methods and pre-clinical validation systems, the platform identifies and positions novel drug candidates to address the limitations of existing cancer treatments.

This company provides a photoporation platform for gentle cell transfection using pulsed laser light and photothermal nanosensitizers. The method creates transient pores in the cell membrane, allowing external payloads to enter the cytosol while minimizing impact on cell viability. This technology supports high-throughput R&D applications and clinical cell therapy manufacturing with flexible payload delivery.

VoxelSensors develops intelligent sensing technology, utilizing Single Photon Active Event Sensors (SPAES) and PERCEPT models, to capture relevant human contextual data for AI agents. This low-power, on-device solution enables personal AI assistants on wearable devices to anticipate user needs and understand context in real-time. The core value is providing high-quality, selective data streams necessary for advancing user-aware spatial and empathic computing applications.